Biotech / BioTech / Boston blog main / National blog main / National top stories / New York / New York blog main / New York top stories / San Francisco blog main / Alexandria Real Estate Equities / Alexandria Venture Investments / Columbia University / deals / Euclidean Capital / Illumina Ventures / incubators / Joel Marcus / Kallyope / Life Sciences / LifeSci NYC / Lodo Therapeutics / Lux Capital / Maria Gotsch / Merck / Nancy Thornberry / New York City Economic Development Corp. / New York Genome Center / nonalcoholic steatohepatitis / obesity / Partnership Fund for New York City / Petra Pharma / Polaris Partners / startups / The Column Group / Tri-Institutional Therapeutics Discovery Institute / Two Sigma Ventures / VC

Will Fast-Growing Kallyope Stay in New York After New $66M Round?

Posted on: Feb 22, 2018   |   Posted by: Biotech Mag Top

Will Fast-Growing Kallyope Stay in New York After New $66M Round?

Kallyope is unusual among biotech startups. Exclusively borne from the work of three Columbia University professors , the company started up in Manhattan, now has more than 40...

Continue reading ...



Other Posts from Biotech Mag Top